Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

Recruiting Phase 2 Phase 3 Interventional Study
Community-acquired Pneumonia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
3 Months – 18
Sex
Any
Trial phase
Phase 2/3
Study type
Interventional
Purpose
Treatment
Participants needed
1,370 (estimated)
Sponsor
St. Justine's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All patients 3 months to 18 years of age attending the pediatric ED and diagnosed with a non-severe pneumonia, will be considered for enrolment. More precisely, the following inclusion criteria will be required: 1. Presence of respiratory symptoms (cough and/or dyspnea) 2…
Contacts

Jocelyn Gravel, MD

514-345-4931

graveljocelyn@hotmail.com

CONTACT

Ariane Boutin, MD

514-345-4931

arianeboutin@gmail.com

CONTACT